Lilly Scores 3 More Zyprexa Dismissals In MDL

Law360, New York (June 26, 2009, 12:00 AM EDT) -- Eli Lilly & Co. has continued its winning streak in the multidistrict litigation over Zyprexa, with a federal judge throwing out three product liability suits alleging the pharmaceutical giant failed to warn of the health risks associated with the blockbuster antipsychotic drug.

Judge Jack B. Weinstein of the U.S. District Court for the Eastern District of New York granted Lilly summary judgment Monday in the three cases, just weeks after dismissing two other suits that were also a part of the MDL earlier in June....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.